J&J, Merck and Bristol Myers CEOs, under fire on Capitol Hill, seek to turn up heat on drug-market middlemenMarket Watch • 02/08/24
Pharma CEOs Will Testify Today Over Prescription Drug Prices: Here's What To Watch ForForbes • 02/08/24
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricingCNBC • 02/08/24
Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill, but experts cite deeper problems under the radarMarket Watch • 02/07/24
Elanco Animal Health agrees to sell aqua business to Merck for $1.3 billion in cashMarket Watch • 02/05/24
Merck (MRK) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/01/24
Merck's fourth-quarter results top estimates, fueled by key cancer drugs and vaccinesMarket Watch • 02/01/24